Role of liver sinusoidal endothelial cells in liver diseases

J Gracia-Sancho, E Caparrós… - Nature reviews …, 2021 - nature.com
Liver sinusoidal endothelial cells (LSECs) form the wall of the hepatic sinusoids. Unlike
other capillaries, they lack an organized basement membrane and have cytoplasm that is …

Liver dysfunction in sepsis.

EA Woźnica, M Inglot, RK Woźnica… - Advances in Clinical …, 2018 - search.ebscohost.com
Despite continuous progress in medicine, sepsis remains the main cause of deaths in the
intensive care unit. Liver failure complicating sepsis/septic shock has a significant impact on …

Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer

R Liu, Y An, W Jia, Y Wang, Y Wu, Y Zhen, J Cao… - Journal of Controlled …, 2020 - Elsevier
The current nanomedicines for cancer therapy based on the enhance permeability and
retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges …

Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis

JG Abraldes, C Villanueva, C Aracil, J Turnes… - Gastroenterology, 2016 - Elsevier
Background & Aims The combination of β-blockers and band ligation is the standard
approach to prevent variceal rebleeding, but bleeding recurs and mortality is high. The lipid …

Cirrhosis as new indication for statins

J Bosch, J Gracia-Sancho, JG Abraldes - Gut, 2020 - gut.bmj.com
In the recent years, there have been an increasing number of reports on favourable effects of
statins in patients with advanced chronic liver disease. These include reduction in portal …

Reversal of liver fibrosis: from fiction to reality

ME Zoubek, C Trautwein, P Strnad - Best Practice & Research Clinical …, 2017 - Elsevier
In chronic liver diseases, an ongoing hepatocellular injury together with inflammatory
reaction results in activation of hepatic stellate cells (HSCs) and increased deposition of …

Statin use and risk of cirrhosis and related complications in patients with chronic liver diseases: a systematic review and meta-analysis

RG Kim, R Loomba, LJ Prokop, S Singh - Clinical gastroenterology and …, 2017 - Elsevier
Background & Aims Statins have been variably shown to decrease risk and complications of
chronic liver diseases (CLDs). We performed a systematic review and meta-analysis to …

Statins are associated with a decreased risk of decompensation and death in veterans with hepatitis C–related compensated cirrhosis

A Mohanty, JP Tate, G Garcia-Tsao - Gastroenterology, 2016 - Elsevier
Background & Aims Statins decrease portal pressure in patients with cirrhosis and increase
survival times of patients who have bled from varices. However, statins can be hepatotoxic. It …

KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins

G Marrone, R Maeso-Díaz, G García-Cardena… - Gut, 2015 - gut.bmj.com
Objective In the liver, the transcription factor, Kruppel-like factor 2 (KLF2), is induced early
during progression of cirrhosis to lessen the development of vascular dysfunction; …

[HTML][HTML] Simvastatin prevents progression of acute on chronic liver failure in rats with cirrhosis and portal hypertension

DM Tripathi, M Vilaseca, E Lafoz, H Garcia-Caldero… - Gastroenterology, 2018 - Elsevier
Background & Aims Cirrhosis and its clinical consequences can be aggravated by bacterial
infections, ultimately leading to the development of acute on chronic liver failure (ACLF) …